These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8762329)

  • 41. Basaloid-squamous carcinoma of the nasopharynx. An Epstein-Barr virus-associated neoplasm compared with morphologically identical tumors occurring in other sites.
    Wan SK; Chan JK; Lau WH; Yip TT
    Cancer; 1995 Nov; 76(10):1689-93. PubMed ID: 8625035
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Diagnostic utility of immunohistochemical analysis and Epstein-Barr virus-encoded small RNAs in situ hybridisation of cell block sections obtained using fine-needle aspiration in nasopharyngeal carcinoma with lymph node metastasis.
    Zhang Y; Yu X; Yang Y; Wang Y; Chen S; Zhou X
    Diagn Cytopathol; 2019 Mar; 47(3):200-205. PubMed ID: 30593738
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Laboratory markers of tumor burden in nasopharyngeal carcinoma: a comparison of viral load and serologic tests for Epstein-Barr virus.
    Fan H; Nicholls J; Chua D; Chan KH; Sham J; Lee S; Gulley ML
    Int J Cancer; 2004 Dec; 112(6):1036-41. PubMed ID: 15386346
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Epstein-Barr virus carriage by nasopharyngeal carcinoma in situ.
    Yeung WM; Zong YS; Chiu CT; Chan KH; Sham JS; Choy DT; Ng MH
    Int J Cancer; 1993 Mar; 53(5):746-50. PubMed ID: 8383629
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In situ localization of Epstein-Barr virus encoded RNA in non-nasal/nasopharyngeal CD56-positive and CD56-negative T-cell lymphomas.
    Tsang WY; Chan JK; Yip TT; Ng CS; Wong KF; Poon YF; Ma VW
    Hum Pathol; 1994 Aug; 25(8):758-65. PubMed ID: 7520016
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Circulating Epstein-Barr virus microRNAs miR-BART7 and miR-BART13 as biomarkers for nasopharyngeal carcinoma diagnosis and treatment.
    Zhang G; Zong J; Lin S; Verhoeven RJ; Tong S; Chen Y; Ji M; Cheng W; Tsao SW; Lung M; Pan J; Chen H
    Int J Cancer; 2015 Mar; 136(5):E301-12. PubMed ID: 25213622
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Beta 2-microglobulin and HLA-DR expression in relation to the presence of Epstein-Barr virus in nasopharyngeal carcinomas.
    Kouvidou C; Rontogianni D; Tzardi M; Datseris G; Panayiotides I; Darivianaki K; Karidi E; Delides G; Kanavaros P
    Pathobiology; 1995; 63(6):320-7. PubMed ID: 8738471
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reactive nitrogen species-dependent DNA damage in EBV-associated nasopharyngeal carcinoma: the relation to STAT3 activation and EGFR expression.
    Ma N; Kawanishi M; Hiraku Y; Murata M; Huang GW; Huang Y; Luo DZ; Mo WG; Fukui Y; Kawanishi S
    Int J Cancer; 2008 Jun; 122(11):2517-25. PubMed ID: 18307254
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Differential expression of Epstein-Barr virus-encoded RNA and several tumor-related genes in various types of nasopharyngeal epithelial lesions and nasopharyngeal carcinoma using tissue microarray analysis.
    Fan SQ; Ma J; Zhou J; Xiong W; Xiao BY; Zhang WL; Tan C; Li XL; Shen SR; Zhou M; Zhang QH; Ou YJ; Zhuo HD; Fan S; Zhou YH; Li GY
    Hum Pathol; 2006 May; 37(5):593-605. PubMed ID: 16647958
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Detection of occult nasopharyngeal primary tumours by means of in situ hybridization.
    Feinmesser R; Feinmesser M; Freeman JL; Noyek AM; Livni N
    J Laryngol Otol; 1992 Apr; 106(4):345-8. PubMed ID: 1319444
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Unusual coexistence of extramedullary plasmacytoma and nasopharyngeal carcinoma in nasopharynx.
    Du RC; Li HN; Huang W; Tian XY; Li Z
    Diagn Pathol; 2015 Sep; 10():170. PubMed ID: 26376733
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Screening nasopharyngeal carcinoma by detection of the latent membrane protein 1 (LMP-1) gene with nasopharyngeal swabs.
    Hao SP; Tsang NM; Chang KP
    Cancer; 2003 Apr; 97(8):1909-13. PubMed ID: 12673717
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Identification of aberrant cell cycle regulation in Epstein-Barr virus-associated nasopharyngeal carcinoma by cDNA microarray and gene set enrichment analysis.
    Zhang W; Zeng Z; Zhou Y; Xiong W; Fan S; Xiao L; Huang D; Li Z; Li D; Wu M; Li X; Shen S; Wang R; Cao L; Tang K; Li G
    Acta Biochim Biophys Sin (Shanghai); 2009 May; 41(5):414-28. PubMed ID: 19430707
    [TBL] [Abstract][Full Text] [Related]  

  • 54. MicroRNAs: potential diagnostic markers and therapeutic targets for EBV-associated nasopharyngeal carcinoma.
    He ML; Luo MX; Lin MC; Kung HF
    Biochim Biophys Acta; 2012 Jan; 1825(1):1-10. PubMed ID: 21958739
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Epstein-Barr virus in oropharyngeal and nasopharyngeal secretions of patients with nasopharyngeal carcinoma and control subjects.
    Tsao SY; He Y; Cheng PM; Ho S; Leung SF; Chang RS
    Intervirology; 1991; 32(4):209-15. PubMed ID: 1650762
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Comparison of Epstein-Barr virus in nasopharynx tissue and desquamatine cell for diagnosis of nasopharyngeal carcinoma].
    Sun Z; Xiao C; Jiang W; Feng X; Liu Y
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2006 Feb; 20(4):153-4. PubMed ID: 16711437
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of plasma Epstein-Barr virus DNA load to distinguish nasopharyngeal carcinoma patients from healthy high-risk populations in Southern China.
    Ji MF; Huang QH; Yu X; Liu Z; Li X; Zhang LF; Wang P; Xie SH; Rao HL; Fang F; Guo X; Liu Q; Hong MH; Ye W; Zeng YX; Cao SM
    Cancer; 2014 May; 120(9):1353-60. PubMed ID: 24477877
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Epstein-Barr Virus in Nasopharyngeal Carcinoma of Guatemalan and Brazilian Patients.
    Rumayor Piña A; Dos Santos HT; Carlos R; Altemani A; de Almeida OP
    Int J Surg Pathol; 2017 Jun; 25(4):304-309. PubMed ID: 27881609
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Monitoring tumor recurrence with nasopharyngeal swab and latent membrane protein-1 and epstein-barr nuclear antigen-1 gene detection in treated patients with nasopharyngeal carcinoma.
    Hao SP; Tsang NM; Chang KP
    Laryngoscope; 2004 Nov; 114(11):2027-30. PubMed ID: 15510036
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Nasopharyngeal Epstein-Barr Virus Load: An Efficient Supplementary Method for Population-Based Nasopharyngeal Carcinoma Screening.
    Chen Y; Zhao W; Lin L; Xiao X; Zhou X; Ming H; Huang T; Liao J; Li Y; Zeng X; Huang G; Ye W; Zhang Z
    PLoS One; 2015; 10(7):e0132669. PubMed ID: 26151639
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.